glp 1 discovery The GLP-1 revolution: What UAB researchers are discovering about how these drugs work Frontiers | GLP-1 receptor agonists:

Reducing oxidative stress and inhibiting inflammation at the site of injury

Replacement treatment using human adiponectin may help identify therapeutic targets for preventing and treating metabolic diseases, including insulin resistance and type 2 diabetes (194)

"Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model." Annals of Clinical & Laboratory Science A study indicating the regenerative influence of AOD-9604 on joint cartilage

Benefits typically appear within 24 to 48 hours and last 1 to 2 weeks

If the patient meets FDA labeling criteria for a GLP-1 agent (BMI 30, or BMI 27 with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia), the clinician issues a prescription